- Home
- DMLP vs AZTA Comparison
DMLP vs AZTA Comparison
Compare DMLP & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMLP
- AZTA
- Stock Information
- Founded
- DMLP 2003
- AZTA 1978
- Country
- DMLP United States
- AZTA United States
- Employees
- DMLP N/A
- AZTA N/A
- Industry
- DMLP Oil & Gas Production
- AZTA Industrial Machinery/Components
- Sector
- DMLP Energy
- AZTA Technology
- Exchange
- DMLP Nasdaq
- AZTA Nasdaq
- Market Cap
- DMLP 1.3B
- AZTA 1.4B
- IPO Year
- DMLP N/A
- AZTA 1995
- Fundamental
- Price
- DMLP $24.20
- AZTA $29.84
- Analyst Decision
- DMLP
- AZTA Buy
- Analyst Count
- DMLP 0
- AZTA 4
- Target Price
- DMLP N/A
- AZTA $42.00
- AVG Volume (30 Days)
- DMLP 145.6K
- AZTA 706.4K
- Earning Date
- DMLP 08-07-2025
- AZTA 08-05-2025
- Dividend Yield
- DMLP 13.30%
- AZTA N/A
- EPS Growth
- DMLP N/A
- AZTA N/A
- EPS
- DMLP 1.71
- AZTA N/A
- Revenue
- DMLP $161,859,000.00
- AZTA $668,821,000.00
- Revenue This Year
- DMLP N/A
- AZTA N/A
- Revenue Next Year
- DMLP N/A
- AZTA $4.74
- P/E Ratio
- DMLP $14.22
- AZTA N/A
- Revenue Growth
- DMLP 4.04
- AZTA 12.46
- 52 Week Low
- DMLP $24.01
- AZTA $23.91
- 52 Week High
- DMLP $34.88
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- DMLP 24.01
- AZTA 45.74
- Support Level
- DMLP $24.01
- AZTA $29.76
- Resistance Level
- DMLP $25.25
- AZTA $31.16
- Average True Range (ATR)
- DMLP 0.60
- AZTA 1.48
- MACD
- DMLP -0.17
- AZTA -0.04
- Stochastic Oscillator
- DMLP 5.97
- AZTA 54.60
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.